Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 2
1960 2
1986 1
1987 1
1988 3
1989 1
1990 3
1991 9
1992 5
1993 7
1994 7
1995 10
1996 15
1997 4
1998 13
1999 14
2000 13
2001 20
2002 26
2003 20
2004 22
2005 33
2006 18
2007 18
2008 26
2009 28
2010 29
2011 26
2012 35
2013 33
2014 63
2015 49
2016 41
2017 49
2018 50
2019 39
2020 48
2021 58
2022 55
2023 56
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

899 results

Results by year

Filters applied: . Clear all
Page 1
HIV-1 RNA monitoring with a dual-target diagnostic assay: A case report.
Sberna G, Gagliardini R, Rozera G, Forbici F, Cicalini S, Antinori A, Maggi F, Amendola A. Sberna G, et al. Among authors: antinori a. Heliyon. 2024 Apr 19;10(9):e29842. doi: 10.1016/j.heliyon.2024.e29842. eCollection 2024 May 15. Heliyon. 2024. PMID: 38699019 Free PMC article.
Human and Viral microRNA Expression in Acute and Chronic HIV Infections.
Lazzari E, Rozera G, Gagliardini R, Esvan R, Mondi A, Mazzotta V, Camici M, Girardi E, Antinori A, Maggi F, Abbate I. Lazzari E, et al. Among authors: antinori a. Viruses. 2024 Mar 23;16(4):496. doi: 10.3390/v16040496. Viruses. 2024. PMID: 38675839 Free PMC article.
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093/cid/ciae228. Online ahead of print. Clin Infect Dis. 2024. PMID: 38663013
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV.
Vergori A, Cozzi-Lepri A, Tavelli A, Mazzotta V, Azzini AM, Gagliardini R, Mastrorosa I, Latini A, Pellicanò G, Taramasso L, Ceccherini-Silberstein F, Giannella M, Tacconelli E, Marchetti G, Monforte AD, Antinori A; Vax ICONA ORCHESTRA Study group. Vergori A, et al. Among authors: antinori a. Int J Infect Dis. 2024 Apr 19;144:107065. doi: 10.1016/j.ijid.2024.107065. Online ahead of print. Int J Infect Dis. 2024. PMID: 38643867 Free article.
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
Matusali G, Vergori A, Cimini E, Mariotti D, Mazzotta V, Lepri AC, Colavita F, Gagliardini R, Notari S, Meschi S, Fusto M, Tartaglia E, Girardi E, Maggi F, Antinori A; HIV‐VAC Study Group. Matusali G, et al. Among authors: antinori a. J Med Virol. 2024 Apr;96(4):e29598. doi: 10.1002/jmv.29598. J Med Virol. 2024. PMID: 38624044
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
Vergori A, Cozzi Lepri A, Chiuchiarelli M, Mazzotta V, Metafuni E, Matusali G, Siciliano V, Paulicelli J, Alma E, Siniscalchi A, Sica S, Abruzzese E, Fantoni M, Antinori A, Cingolani A. Vergori A, et al. Among authors: antinori a. Int J Infect Dis. 2024 Apr 12;144:107042. doi: 10.1016/j.ijid.2024.107042. Online ahead of print. Int J Infect Dis. 2024. PMID: 38614231 Free article.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. Among authors: antinori a. J Antimicrob Chemother. 2024 Apr 6:dkae081. doi: 10.1093/jac/dkae081. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38581349
Two-meshes approach in posterior component separation with transversus abdominis release: the IMPACT study (Italian Multicentric Posterior-separation Abdominal Complex hernia Transversus-release).
Pizza F, Maida P, Bertoglio C, Antinori A, Mongardini FM, Cerbara L, Sordelli I, Alampi BD, Marte G, Morini L, Grimaldi S, Gili S, Docimo L, Gambardella C. Pizza F, et al. Among authors: antinori a. Hernia. 2024 Apr 3. doi: 10.1007/s10029-024-03001-3. Online ahead of print. Hernia. 2024. PMID: 38568350
899 results